Mitochondrial DNA depletion in progressive external ophthalmoplegia caused by POLG1 mutations

Department of Neurology, Haukeland University Hospital, Bergen, Norway.
Acta neurologica Scandinavica. Supplementum 08/2009; 120(189):38-41. DOI: 10.1111/j.1600-0404.2009.01212.x
Source: PubMed

ABSTRACT To investigate two patients with late onset, progressive external ophthalmoplegia (PEO) and sensory peripheral neuropathy.
The patients aged 86 and 50 years were investigated clinically including magnetic resonance imaging of the brain, electrophysiological studies and, in one, skeletal muscle biopsy. Molecular studies included sequencing of the whole coding region of the POLG1 gene and mitochondrial DNA (mtDNA) analysis for deletions and depletion.
Both patients were compound heterozygous for gene encoding the catalytic subunit of the DNA-polymerase gamma (POLG1) mutations. One had the p.737R and p.W748S mutations while the other carried the p.T251I, p.P587L and p.W748S mutations. While these mutations have been previously described, these combinations are novel. mtDNA studies in skeletal muscle showed evidence of multiple deletions and approximately 64% depletion of the mitochondrial genome.
Our findings broaden the genotypic spectrum of POLG-associated PEO and show that in addition to multiple deletions, mtDNA depletion occurs and may contribute to the pathogenesis of this disorder.

  • Neurology 11/2011; 77(20):1847-52. DOI:10.1212/WNL.0b013e318238863a · 8.30 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Valproic acid is a widely-used first-generation antiepileptic drug, prescribed predominantly in epilepsy and psychiatric disorders. VPA has good efficacy and pharmacoeconomic profiles, as well as a relatively favorable safety profile. However, adverse drug reactions have been reported in relation with valproic acid use, either as monotherapy or polytherapy with other antiepileptic drugs or antipsychotic drugs. This systematic review discusses valproic acid adverse drug reactions, in terms of hepatotoxicity, mitochondrial toxicity, hyperammonemic encephalopathy, hypersensitivity syndrome reactions, neurological toxicity, metabolic and endocrine adverse events, and teratogenicity.
    Clinical biochemistry 06/2013; 46(15). DOI:10.1016/j.clinbiochem.2013.06.012 · 2.23 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The different stages of the geodynamic evolution of Neoproterozoic basins in southwestern Africa were accompanied by a variety of mineralisation processes. These range from synsedimentary-exhalative base metal deposits in continental rift basins, Besshi-type cupriferous pyrite deposits in oceanic crustal rocks, syn-orogenic polymetallic Tsumeb-type mineralisation in foreland carbonate platforms, orogenic gold and magmatic U and Sn deposits, to REE-rich pegmatites and post-orogenic enrichment in the supergene zone. Of currently main economic significance amongst these are the Pb and Zn deposits around Rosh Pinah in the external Gariep Belt, the Tsumeb-type deposits at Kombat and the alaskite-hosted U deposits in the western part of the Central Zone in the Damara Belt.